Quarterly report [Sections 13 or 15(d)]

Restructuring (Details)

Restructuring (Details) $ in Thousands	3 Months Ended					6 Months Ended		9 Months Ended
Restructuring (Details) $ in Thousands	Dec. 31, 2025 USD ($)	Sep. 30, 2025 USD ($) installment	Jun. 30, 2025 USD ($)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Jun. 30, 2025 USD ($)
Restructuring
Recovery of assets held-for-sale						$ 6,789
Fair Value, Recurring \| Other Noncurrent Assets
Restructuring
Notes receivable	$ 7,179		$ 2,184			7,179		$ 2,184
Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring reserve, beginning of period		$ 1,101				1,101
Restructuring costs	3,296		95,631			3,421
Cash payments						(10,345)
Non-cash adjustments			(94,530)			6,789
Restructuring reserve, end of period	966		1,101			966		1,101
Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring reserve, beginning of period		1,222				1,222
Restructuring costs	$ 442			$ 2,964	$ 10,269	$ 1,039	$ 13,233	4,148
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of Goods and Services Sold					Cost of Goods and Services Sold
Cash payments						$ (1,726)		(3,354)
Non-cash adjustments								(9,841)
Restructuring reserve, end of period	$ 535		1,222			535		1,222
Protein Sciences \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	2,895					6,103
Protein Sciences \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs	442			2,794		1,039	12,485
Diagnostics and Spatial Biology \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs						(3,823)
Diagnostics and Spatial Biology \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				(19)			425
Exosome Diagnostics \| Restructuring Plan to Optimize Global Manufacturing \| Fair Value, Recurring
Restructuring
Notes receivable	9,000					9,000
Exosome Diagnostics \| Disposed of by Sale \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Consideration for sale		15,000
Consideration as stock		6,800
Recovery of assets held-for-sale		$ 6,800
No. of installments \| installment		4
Installment amount		$ 2,500
Stock consideration receivable		5,000
Exosome Diagnostics \| Held for sale
Restructuring
Cumulative impairment charge			83,100
Exosome Diagnostics \| Held for sale \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Goodwill attributable to disposal group held for sale			4,500					4,500
Corporate \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	401					1,141
Corporate \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				189			323
Cost of Sales \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	1,472					2,954
Cost of Sales \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				2,691			7,589
Selling, General and Administrative Expenses \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	1,824					467
Selling, General and Administrative Expenses \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				273			5,644
Employee severance \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring reserve, beginning of period		1,041				1,041
Restructuring costs	278		1,041			5,620
Cash payments						(5,890)
Restructuring reserve, end of period	771		1,041			771		1,041
Employee severance \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring reserve, beginning of period		1,222				1,222
Restructuring costs	278			205	2,852	698	3,057	593
Cash payments						(1,385)		(2,223)
Restructuring reserve, end of period	535		1,222			535		1,222
Employee severance \| Protein Sciences \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	182					1,818
Employee severance \| Protein Sciences \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs	278			39		698	2,313
Employee severance \| Diagnostics and Spatial Biology \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs						2,966
Employee severance \| Diagnostics and Spatial Biology \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				(19)			425
Employee severance \| Corporate \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	96					836
Employee severance \| Corporate \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				185			319
Asset-related and other \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring reserve, beginning of period		$ 60				60
Restructuring costs	3,018		11,531			4,590
Cash payments						(4,455)
Non-cash adjustments			(11,471)
Restructuring reserve, end of period	195		60			195		60
Asset-related and other \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs	164			2,759	$ 7,417	341	10,176	3,555
Cash payments						(341)		(1,131)
Non-cash adjustments								$ (9,841)
Asset-related and other \| Protein Sciences \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	2,713					4,285
Asset-related and other \| Protein Sciences \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs	164			2,755		341	10,172
Asset-related and other \| Corporate \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	$ 305					305
Asset-related and other \| Corporate \| Restructuring Plan to Recover Operating Margins
Restructuring
Restructuring costs				$ 4			$ 4
Impairment (Recovery) Of Assets Held For Sale [Member] \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			83,059			(6,789)
Non-cash adjustments			$ (83,059)			6,789
Impairment (Recovery) Of Assets Held For Sale [Member] \| Diagnostics and Spatial Biology \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs						$ (6,789)